The amazing spiny mouse, the champion of mammalian regeneration
Malcolm Maden, Department of Biology & UF Genetics Institute, Gainesville, Florida, USA shares his expert opinion on the amazing spiny mouse, the champion of mammalian regeneration
Microbes and the rigour of space flight
William B. Miller, Jr., M.D. argues that without the planning to do so, we have launched microbial life from this planet
8 in 10 transport firms eligible for Research and Development tax relief
Recent findings from Catax, a specialist tax relief firm, has revealed that the majority of transport firms in the UK could claim for Research and Development (R&D) relief, but only a quarter are aware it even exists
EU Research Commissioner fights to protect a €100 billion investment
The EU’s research Commissioner, Carlos Moedas has demanded more commitment from member states on research and innovation spending, despite a widespread sense of reluctance throughout the European Union to increase the budget.
At the frontier of brain tumour research, we must leave no stone unturned
With the Government set to invest an additional £20 million into the research, diagnosis and development of treatments for brain tumours, Dr Ali Hansford elaborates on the need to talk more about how we are going to find the next blockbuster treatments for these devastating diseases
Multiverse theories in physics from the vantage point of philosophy
Dr Simon Friederich from University College Groningen sheds light on multiverse theories in physics from the perspective of philosophy
A renewable agenda for research and innovation
The European Commission today presents its contribution to the informal discussion that Heads of State and Government will hold in Sofia on 16 May 2018 on research and innovation and the steps needed to ensure Europe's global competitiveness
Cancer immunotherapy therapy is here and now
Stephanie K. Watkins PhD from Loyola University Chicago shares her views on cancer immunotherapy therapy – the concept of using the immune system to fight and destroy cancer cells
ALS researchers begin recreating human spinal cords on a chip
NIH-funded study closes in on personalised drug testing for neurological disorders
Essential malaria parasite genes revealed
NIAID-funded research could aid antimalarial drug development
Is 2018 the year we will see a cure for Thalassemia?
Multiple breakthroughs in gene therapy offer new hope for patients with genetic blood disorder, most common in Middle Eastern, Mediterranean, South Asian and African populations
Technological expertise in the electronics sector
Bomare Company, the first Algerian exporter of electronic products to the European market, lifts the lid on their work concerning technology in the electronics sector
Escherichia coli evolution from the lab, to the mice gut and the wild
Professor Olivier Tenaillon from IAME -INSERM outlines the evolution of Escherichia coli (E. coli) from the lab, to the mice gut and the wild
Space: Reaching out to new heights to benefit mankind
Open Access Government reveals the exciting mission of the National Aeronautics and Space Administration (NASA) and how the United States aims to reach out to new heights to benefit mankind when it comes to exploring space and beyond
Research, science and innovation in Europe
Open Access Government places the excellent work of European Commissioner for Research, Science and Innovation Carlos Moedas under the spotlight
Supporting the earth sciences in the United States
The Earth Sciences (EAR) Division of the National Science Foundation (NSF) is placed under the spotlight by Open Access Government
Do we know what red blood cells look like?
Anna Bogdanova, Professor and Head of Red Blood Cell Research Group at the University of Zurich explains how we know how red blood cells look like and if so, what they tell us
Assessing endocrine disrupting chemicals (EDC)
Alberto Mantovani presents the contribution of the Istituto Superiore di Sanità (ISS) to the international assessment of endocrine disrupting chemicals (EDC)
Diabetes & peripheral arterial disease
A change of paradigm improves patients’ outcomes with diabetes & peripheral arterial disease, according to the Division of Angiology at the Medical University of Vienna
Cancer research and training in the United States
The work of the National Cancer Institute (NCI), the federal government’s principal agency for cancer research and training in the United States, is profiled here by Open Access Government
